Clinical data on Fluarix: an inactivated split seasonal influenza vaccine (Q31166045)

29 June 2017

1 reference

title

Clinical data on Fluarix: an inactivated split seasonal influenza vaccine (English)

1 reference

29 June 2017

1 reference

2

Wendy A Keitel

1 reference

29 June 2017

Hana M El Sahly

1

1 reference

29 June 2017

1 August 2008

1 reference

Expert Review of Vaccines

29 June 2017

1 reference

29 June 2017

7

1 reference

29 June 2017

6

1 reference

29 June 2017

713-719

1 reference

Epidemiology and seasonality of respiratory tract virus infections in the tropics

29 June 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Mortality during influenza epidemics in the United States, 1967-1978.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

The impact of influenza epidemics on mortality: introducing a severity index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Influenza and the rates of hospitalization for respiratory disease among infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Effectiveness of influenza vaccine in the community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Herd protection against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Antibody response to influenza vaccination in the elderly: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Immunity to influenza in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Immunosenescence: role and measurement in influenza vaccine response among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Influenza vaccination in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Antibody response to influenza vaccination in splenectomized patients in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Influenza Vaccination Among the Elderly in the United States—Reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Influenza-Associated Deaths among Children in the United States, 2003–2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Emerging vaccines for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

Influenza and pneumonia hospitalizations in Ontario: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.713

21 January 2018

Identifiers

DOI

10.1586/14760584.7.6.713

1 reference

29 June 2017

1 reference

PubMed ID

18665769